Determination of myeloperoxidase in EDTA plasma: Comparison of an enzyme-linked immunosorbent assay with a chemiluminescent automated immunoassay

Clinica Chimica Acta

Volumn 406, Issue 1-2, 2009, Pages 62-65

  Zelzer, Sieglinde ^a   Khoschsorur, GholamAli ^a   Stettin, Mariana ^a   Weihrauch, Gisela ^a   Truschnig Wilders, Martini ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Automated chemiluminescent immunoassay; Cardiovascular diseases; ELISA; Myeloperoxidase; Transplant recipients

Indexed keywords

EDETIC ACID; MYELOPEROXIDASE;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHEMILUMINESCENT AUTOMATED IMMUNOASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL; RECIPIENT; TRANSPLANTATION;

AUTOMATION; EDETIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUMINESCENCE; PEROXIDASE; TRANSPLANTATION;

EID: 67650214712     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.05.009     Document Type: Article

References (22)

1. Winterbourn C.C., Vissers M.C.M., and Kettle A.J. Myeloperoxidase. Curr Opin Hematol 7 (2000) 53-58
2. Daugherty A., Dunn J.L., Rateri D., and Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94 (1994) 437-444
3. Zheng L., Nukuna B., Brennan M.L., et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114 (2004) 529-541
4. Podrez E.A., Schmitt D., Hoff H.F., and Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 103 (1999) 1547-1560
5. Shao B., Oda M.N., Oram J.F., and Heinecke J.W. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr Opin Cardiol 21 (2006) 322-328
6. Abu-Soud H.M., and Hazen S.L. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 275 (2000) 37524-37532
7. Eiserich J.P., Baldus S., Brennan M.L., et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296 (2002) 2391-2394
8. Nicholls S.J., and Hazen S.L. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 1102-1111
9. Sugiyama S., Kugiyama K., and Aikawa M. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 24 (2004) 1309-1314
10. Brennan M.L., Penn M.S., Van Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
11. Baldus S., Heeschen C., Meinertz T., et al. CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
12. Stefanescu A., Braun S., Ndrepepa G., et al. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease. Am Heart J 155 (2008) 356-360
13. Zelzer S., Stiegler P., Kapitan M., et al. Myeloperoxidase as serum marker for detection of CMV infections and rejections in patients after liver or heart transplantation. Transpl Immunol 20 (2009) 121-126
14. Meuwese M.C., Stroes E.S., Hazen S.L., et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 50 (2007) 159-165
15. Esporcatte R., Rey H.C., Rangel F.O., et al. Predictive value of myeloperoxidase to identify high risk patients admitted to the hospital with acute chest pain. Arq Bras Cardiol 89 (2007) 377-384
16. Shih J., Datwyler S.A., Hsu S.C., et al. Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations. Clin Chem 54 (2008) 1076-1079
17. Passing H., and Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 21 (1983) 709-720
18. Bland J.M., and Altmann D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
19. R Myeloperoxidase (MPO) assay in development [Abstract]. Clin Chem Lab Med 45 (2007) T051
20. Chang P.Y., Wu T.L., Hung C.C., et al. Development of an ELISA for myeloperoxidase on microplate: normal reference values and effect of temperature on specimen preparation. Clin Chim Acta 373 (2006) 158-163
21. Roman R.M., Wendland A.E., and Polanczyk C.A. Myeloperoxidase and coronary arterial disease: from research to clinical practice. Arq Bras Cardiol 91 (2008) 11-19
22. Lavi S., Prasad A., Yang E.H., et al. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation 115 (2007) 2621-2627